Code | 5285A | ||||||||||
MA number | EU/1/08/454/010 | ||||||||||
Product Form: | plv iol 5x300 µg (liek.inj.skl.)+5x1,2 ml solv.(striek.inj.napl.-Luerov uzáver) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Novartis Europharm Limited, Ireland | ||||||||||
Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Container: | glass vial | ||||||||||
Route of admin.: | Subcutaneous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 10c informed consent application |
MA issued: | 05.04.2013 |
SmPC + PL: | European Medicines Agency's database |
Dokument: | DHPC interferóny final 25 8 2014.pdf |
Safety feature | Yes |
Data update: | 18.06.2018 |